BSX — Boston Scientific Balance Sheet
0.000.00%
Last trade - 00:00
- $98.97bn
- $107.45bn
- $14.24bn
- 94
- 16
- 98
- 78
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 217 | 1,734 | 1,925 | 928 | 865 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1,828 | 1,531 | 1,778 | 1,970 | 2,228 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 4,699 | 6,694 | 6,317 | 5,760 | 6,514 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 2,415 | 2,542 | 2,687 | 2,832 | 3,298 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 30,565 | 30,777 | 32,229 | 32,469 | 35,136 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 4,866 | 3,681 | 4,274 | 3,803 | 4,933 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 16,688 | 15,451 | 15,607 | 14,896 | 15,854 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 13,877 | 15,326 | 16,622 | 17,573 | 19,282 |
Total Liabilities & Shareholders' Equity | 30,565 | 30,777 | 32,229 | 32,469 | 35,136 |
Total Common Shares Outstanding |